Source disclosure: February 13, 2026

RaQualia Pharma Inc. [4579.T]

TOKYO, Feb 23 (Pulse News Wire) – Raqualia Pharma Inc. (4579.T) reported consolidated results for fiscal year 2025 ending December.

98 billion (+28.1% YoY).

5 billion with an equity ratio of 65.1%.

For the next fiscal year, the company forecasts 98 billion.

Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.

AI-translated content. 🟢 Confidence: High See terms •

Financial results — FY2025/12 (consolidated)

MetricCurrentYoY
Revenue¥3,979M+28.1%
Operating profit¥483M+437.0%
Net profitn/an/a

Next period forecast

Revenue

¥3,980M

+165.0%

Op. profit

¥-65M

+86.0%

Net profit

¥-2M

n/a

Source: TDNet filing · Figures in millions of yen

Original filing

💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.
🎁 Report 3+ errors with your email and get a free month of premium access